These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans. Watzka M; Westhofen P; Hass M; Marinova M; Pötzsch B; Oldenburg J Thromb Haemost; 2009 Aug; 102(2):418-20. PubMed ID: 19652895 [No Abstract] [Full Text] [Related]
13. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Napolitano M; Mariani G; Lapecorella M Orphanet J Rare Dis; 2010 Jul; 5():21. PubMed ID: 20630065 [TBL] [Abstract][Full Text] [Related]
14. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586 [TBL] [Abstract][Full Text] [Related]
15. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Wadelius M; Chen LY; Downes K; Ghori J; Hunt S; Eriksson N; Wallerman O; Melhus H; Wadelius C; Bentley D; Deloukas P Pharmacogenomics J; 2005; 5(4):262-70. PubMed ID: 15883587 [TBL] [Abstract][Full Text] [Related]
16. Characterization of vitamin K-dependent carboxylase mutations that cause bleeding and nonbleeding disorders. Tie JK; Carneiro JD; Jin DY; Martinhago CD; Vermeer C; Stafford DW Blood; 2016 Apr; 127(15):1847-55. PubMed ID: 26758921 [TBL] [Abstract][Full Text] [Related]
17. Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis. de Visser MC; Roshani S; Rutten JW; van Hylckama Vlieg A; Vos HL; Rosendaal FR; Reitsma PH Thromb Haemost; 2011 Sep; 106(3):563-5. PubMed ID: 21800014 [No Abstract] [Full Text] [Related]
18. GGCX mutations show different responses to vitamin K thereby determining the severity of the hemorrhagic phenotype in VKCFD1 patients. Ghosh S; Kraus K; Biswas A; Müller J; Buhl AL; Forin F; Singer H; Höning K; Hornung V; Watzka M; Czogalla-Nitsche KJ; Oldenburg J J Thromb Haemost; 2021 Jun; 19(6):1412-1424. PubMed ID: 33590680 [TBL] [Abstract][Full Text] [Related]
19. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin. Vecsler M; Loebstein R; Almog S; Kurnik D; Goldman B; Halkin H; Gak E Thromb Haemost; 2006 Feb; 95(2):205-11. PubMed ID: 16493479 [TBL] [Abstract][Full Text] [Related]
20. Novel mutation in the gamma-glutamyl carboxylase gene resulting in congenital combined deficiency of all vitamin K-dependent blood coagulation factors. Spronk HM; Farah RA; Buchanan GR; Vermeer C; Soute BA Blood; 2000 Nov; 96(10):3650-2. PubMed ID: 11071668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]